GEHC

Is GEHC a good stock to buy? We came across a bullish thesis on GE HealthCare Technologies Inc. on Astute Optics – US’s Substack. The thesis was published on September 13th, when the stock was trading at $64.25, and GEHC gained 9.30% since then. The gain appears to reflect improving sentiment toward healthcare stocks and continued confidence […]

GE HealthCare is partnering with five global organizations to test its StarGuide GX theranostics imaging system, aiming to improve precision oncology and nuclear medicine.

GE HealthCare will report its third‑quarter earnings later this month, with analysts forecasting double‑digit growth.

CHICAGO & VIENNA, October 20, 2026--GE HealthCare (Nasdaq: GEHC) today announced a global clinical evaluation program spanning three continents and five internationally recognized institutions to assess StarGuide™ GX,i its next-generation digital 4D SPECT/CT system.

GE HealthCare received CE Mark approval for its MINItrace Magni cyclotron in Europe, boosting its PET imaging and theranostics capabilities.

CHICAGO, October 19, 2026--GE HealthCare today announced LOGIQ™ Focus, a new addition to its LOGIQ family of general imaging ultrasound systems, designed to bring advanced imaging tools to a broader range of ultrasound exams.

GE HealthCare Technologies may be undervalued as its imaging push gains traction, following CE Mark approval for MINItrace Magni and expanded Copper‑64 production.

The CE Mark for MINItrace Magni and expanded Copper‑64 support may shift investor focus toward GE HealthCare’s integrated molecular imaging and radiopharmacy platform.